|Articles|December 9, 2022
Migrating a Drug Product from Vial to Pre-Filled Syringe
Author(s)Pfizer CentreOne
This note outlines the benefits of PFS transfer and the key engineering processes required to successfully carry out this process.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
2
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
3
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
4
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
5